ArticlePloS one2018

CB1 receptor blockade ameliorates hepatic fat infiltration and inflammation and increases Nrf2-AMPK pathway in a rat model of severely uncontrolled diabetes.

Eugene Chang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.